A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety
Table 3
Individual and Mean Pharmacokinetic Parameters following a Single Dose Infusion of 10 mCi of 131I-CLR1404.